Showing 1 - 20 results of 16,763 for search '(( c largest decrease ) OR ((( ((c marked) OR (n marked)) decrease ) OR ( b large increases ))))*', query time: 0.65s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Persistence of β-cell responsiveness for over two years in autoantibody-positive children with marked metabolic impairment at screening by Emily K. Sims (5278130)

    Published 2022
    “…Despite marked baseline metabolic impairment of non-progressors, changes in AUC C-peptide, AUC glucose, AUC C-peptide/AUC glucose, and Index60 did not differ from Ab- relatives during follow-up. …”
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    The activation of MARK2 is correlated with the phosphorylation of eIF2α, and the signaling pathway is independent of the previously known kinases. by Yu-Ning Lu (10291271)

    Published 2021
    “…<p>(<b>A</b>) Deletion of the MARK2 gene decreases the phosphorylation of eIF2α-<sup>51</sup>S in human HAP1 cells. …”
  18. 18

    Deletion of microglial NKCC1 markedly impacts on baseline cell morphology and alters transformation to reactive microglia. by Krisztina Tóth (12009827)

    Published 2022
    “…(<b>C)</b> Unpaired <i>t</i> test, <i>N =</i> 3/group. **: <i>p</i> < 0.01. …”
  19. 19

    Deletion of Ssp2 or/and Gsk3/Gsk31 markedly suppressed CLZ, TER or CoCl<sub>2</sub>-induced Sre1 activity. by Hao Miao (1742044)

    Published 2020
    “…<p>The Δ<i>ssp2</i>, Δ<i>gsk3</i>Δ<i>gsk31</i>, Δ<i>ssp2</i>Δ<i>gsk3</i>, Δ<i>ssp2</i>Δ<i>gsk31</i> or Δ<i>ssp2</i>Δ<i>gsk3</i>Δ<i>gsk31</i> cells showed a significant decrease in Sre1 activity and delay in the peak rising of the SRE2 reporter stimulated with 8 μg/ml CLZ (A)<sub>,</sub> 8 μg/ml TER (B) or 0.32 mM CoCl<sub>2</sub> (C). …”
  20. 20